Systematic evaluation of subgroup analyses of inhaled treprostinil in pulmonary hypertension due to interstitial lung disease
Due to methodological limitations, the credibility of subgroup claims from the authors of the INCREASE was lacking and, therefore, should not be relied upon to inform decisions on an individual basis.
Authors
- Remedios Otero (ORCID: https://orcid.org/0000-0002-2265-1221)
- Héctor Rodríguez Ramallo (ORCID: https://orcid.org/0000-0003-1742-251X)
- Laila Abdel‐Kader Martín (ORCID: https://orcid.org/0000-0002-9012-3850)
- Nerea Báez‐Gutiérrez (ORCID: https://orcid.org/0000-0002-9419-7742)
- Pablo Martínez-Puig
Institutions
- Hospital Universitario Virgen Macarena (ES)
- Hospital Universitario Reina Sofía (ES)
- Instituto de Biomedicina de Sevilla (ES)
- Hospital Universitario Virgen del Rocío (ES)
- Universidad de Sevilla (ES)
Publication Details
- Journal
- PLoS ONE
- Published
- 2025-02-12
- DOI
- https://doi.org/10.1371/journal.pone.0318739
- Primary Topic
- Pulmonary Hypertension Research and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 0.00